Dr Cristianne Rijcken
Founder & Chief Scientific Officer

Is this your profile?

About

Cristianne Rijcken, PhD, is Founder and Chief Scientific Officer at Cristal Therapeutics.

Contributions

#97_2019_Cristal_featured

COMPANY SHOWCASE: Cristal Therapeutics

Over the past year, Cristal Therapeutics has transitioned from a research-stage start-up to a fully fledged, clinical-stage business with a promising pipeline of proprietary drug candidates. This diverse pipeline together with the proprietary nanoparticle platform, CriPec^®, presents a broad range of promising late- and early-stage partnering opportunities for companies active in the oncology space.

Top